Physician profile
John Wallace
NPI 1992735302
$1,216.29
in general payments reported to CMS, 2019-2025
17 companies · $155 in 2025
The $155 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $146 · 2020: $191 · 2021: $152 · 2022: $230 · 2023: $168 · 2024: $174 · 2025: $155.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $497.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $186.85 | 2019-2023 | |
| Bausch & Lomb Americas INC. | $134.44 | 2022-2025 | Vyzulta, Xiidra, Miebo |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $117.58 | 2019-2021 | |
| Horizon Therapeutics Plc | $81.97 | 2022-2023 | Tepezza |
| Amgen INC. | $79.47 | 2024-2025 | Tepezza |
| Tarsus Pharmaceuticals, INC. | $66.94 | 2024 | Xdemvy |
| Biotissue Holdings INC. | $65.72 | 2022 | |
| Quidel Corporation | $61.15 | 2020 | |
| Eyevance Pharmaceuticals LLC | $57.28 | 2019-2022 | |
| Allergan, INC. | $54.27 | 2019-2021 | |
| Johnson & Johnson Surgical Vision, INC. | $53.81 | 2020-2021 | |
| Abbvie INC. | $52.78 | 2022-2024 | |
| Aerie Pharmaceuticals, INC. | $49.65 | 2019-2021 | |
| Sun Pharmaceutical Industries INC. | $49.33 | 2020-2022 | |
| Sight Sciences, INC. | $47.37 | 2025 | Omni Surgical System, Sion Surgical Instrument |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $34.51 | 2025 | Tryptyr |
| Ocular Therapeutix, INC. | $23.17 | 2024 | Dextenza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Wallace listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.